In € millions, except earnings per share and dividend (in €) |
2012(1) | 2013 | 2014 | 2015
|
2016 |
|---|---|---|---|---|---|
Order intake |
12,527 | 12,928 | 14,363 | 18,880 | 16,514 |
Order book at end of period |
24,944 | 24,469 | 27,885 | 32,292 | 33,530 |
Sales |
13,131 |
12,698 |
12,974 |
14,063 |
14,885 |
| Total change | + 0.3% | + 2.2% | + 8.4% | + 5.8% | |
| Organic change | + 3.3% | - 1.2% | + 4.5% | + 6.8% | |
EBIT (2) |
848 |
1,011 |
985 |
1,216 |
1,354 |
| In % of sales | 6.5% | 8.0% | 7.6% | 8.6% | 9.1% |
Adjusted net income , Group share (2) |
585 |
642 |
562 |
809 |
897 |
Consolidated net income, Group share |
586 | 573 | 714 | 765 | 946 |
Adjusted net income Group share, per share (EPS)(2) |
2.86 |
3.20 |
2.75 |
3.89 |
4.25 |
Dividend per share |
0.88 | 1.12 | 1.12 | 1.36 | 1.60 |
Free operating cash-flow (2) |
669 |
477 |
501 |
1,110 |
954 |
Net cash position at end of period |
1,528 | 1,077 | 1,006 | 1,978 | 2,366 |
Self-funded R&D(4) |
699 | 638 | 675 | 707 | 743
|
Consolidated headcount at year-end |
61,238 | 59,467 | 61,709 | 62,194 | 64,071 |
- (1) The 2012 financial statements did not include the impact of IFRS10 and IFRS11 standards, and thus included the activity of DCNS for the 35% share controlled by Thales.
To facilitate comparison, the 2012 order intake, order book, sales, EBIT and headcount are shown here excluding DCNS. The other KPIs correspond to the restated 2012 numbers appearing in the 2013 registration document. - (2) Non-GAAP measures. See definition in corresponding registration documents
- (3) Including capitalized R&D